This activity is part 3 in a 3-part webinar curriculum and includes pharmacist-patient counseling vignettes.
Program Description
Therapy regimens for atopic dermatitis (AD) require strict adherence to daily skin care routines and therapies that often must be administered multiple times a day. Pharmacists are key members of the multidisciplinary care team in pediatric AD and can use their training to manage clinical issues and interventions, monitor patient response to therapy, and address barriers to treatment and medication access. Informing caregivers about the proper administration and benefits of newly approved treatments for pediatric patients with AD is a critical step in improving quality of life and reducing disease burden for both patients and caregivers. This webinar features patient counseling videos that will detail communication strategies and caregiver-focused education to ensure effective and appropriate utilization of targeted biologic therapies for pediatric patients with AD.
Target Audience: Retail and specialty pharmacists
Type of Activity: Application
Release date: October 12, 2023
Expiration date: December 12, 2023
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explore how pharmacists can improve access to biologics for the treatment of moderate to severe atopic dermatitis in children
- Explain how pharmacists can collaborate with other members of the multidisciplinary team to improve medication management
- Identify the role of the specialty pharmacist in optimizing therapeutic outcomes through patient and caregiver education
Kelly Bucher Gerard, BS Pharm, RPh, CSP
Clinical Pharmacist
Penn State Health Specialty Pharmacy
Milton S. Hershey Medical Center
Hershey, Pennsylvania
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-23-331-L01-P. The activity is available for CE credit through December 12, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Kelly Bucher Gerard, BS Pharm, RPh, CSP
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Karleen Rush, PharmD; Abigail Dill; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms